City

Houston (1)

Jacksonville (1)

Pittsburgh (1)

Rochester (1)

Winston-Salem (1)

Overall Status

Active, not recruiting (1)

Completed (1)

Sign in for free

Phase

phase 2 (2)

Sponsor

M.D. Anderson Cancer Center (1)

Mayo Clinic (1)

Collaborator

National Cancer Institute (NCI) (2)

Intervention

erlotinib hydrochloride (1)

gemcitabine hydrochloride (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

stage 0is renal pelvis cancer ajcc v8

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Stage 0a Renal Pelvis and Ureter Cancer AJCC v8, Stage 0a Renal Pelvis Cancer AJCC v8, Stage 0a Ureter Cancer AJCC v8 Trial in

Active, not recruiting

Stage 0a Renal Pelvis and Ureter Cancer AJCC v8
+17 more

Gemcitabine Hydrochloride

Jacksonville, Florida
+3 more

Jul 5, 2022

Recurrent Bladder Urothelial Carcinoma, Recurrent Renal Pelvis Urothelial Carcinoma, Recurrent Ureter Urothelial Carcinoma Trial

Completed

Recurrent Bladder Urothelial Carcinoma
+19 more

Erlotinib Hydrochloride

Houston, Texas

M D Anderson Cancer Center

Aug 21, 2020